HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 292/4/C1467    most recent 00575.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Fava, G. Articles by Alpini, G. Search for Related Content PubMed PubMed Citation Articles by Fava, G. Articles by Alpini, G.

GROWTH, DIFFERENTIATION, AND APOPTOSIS

Thyroid hormone inhibits biliary growth in bile duct-ligated rats by PLC/IP₃/Ca²⁺-dependent downregulation of SRC/ERK1/2

¹Central Texas Veterans Health Care System, Departments of ²Medicine and ³Systems Biology and Translation Medicine, ⁴Division of Research and Education, Scott & White and The Texas A&M University System Health Science Center, College of Medicine, Temple; ⁵Department of Gastroenterology, Tohoku University School of Medicine, Aobaku, Sendai, Japan; ⁶Department of Gastroenterology, Polytechnic University of Marche, Ancona, Italy; and Central Texas Veterans Health Care System, Temple, Texas

Submitted 15 November 2006 ; accepted in final form 25 December 2006

The role of the thyroid hormone agonist 3,3',5 L-tri-iodothyronine (T3) on cholangiocytes is unknown. We evaluated the in vivo and in vitro effects of T3 on cholangiocyte proliferation of bile duct-ligated (BDL) rats. We assessed the expression of ₁-, ₂-, ₁-, and ₂-thyroid hormone receptors (THRs) by immunohistochemistry in liver sections from normal and BDL rats. BDL rats were treated with T3 (38.4 µg/day) or vehicle for 1 wk. We evaluated 1) biliary mass and apoptosis in liver sections and 2) proliferation in cholangiocytes. Serum-free T3 levels were measured by chemiluminescence. Purified BDL cholangiocytes were treated with 0.2% BSA or T3 (1 µM) in the absence/presence of U-73122 (PLC inhibitor) or BAPTA/AM (intracellular Ca²⁺ chelator) before measurement of PCNA protein expression by immunoblots. The in vitro effects of T3 (1 µM) on 1) cAMP, IP₃, and Ca²⁺ levels and 2) the phosphorylation of Src Tyr139 and Tyr530 (that, together, regulate Src activity) and ERK1/2 of BDL cholangiocytes were also evaluated. ₁-, ₂-, ₁-, and ₂-THRs were expressed by bile ducts of normal and BDL rats. In vivo, T3 decreased cholangiocyte proliferation of BDL rats. In vitro, T3 inhibition of PCNA protein expression was blocked by U-73122 and BAPTA/AM. Furthermore, T3 1) increased IP₃ and Ca²⁺ levels and 2) decreased Src and ERK1/2 phosphorylation of BDL cholangiocytes. T3 inhibits cholangiocyte proliferation of BDL rats by PLC/IP₃/Ca²⁺-dependent decreased phosphorylation of Src/ERK1/2. Activation of the intracellular signals triggered by T3 may modulate the excess of cholangiocyte proliferation in liver diseases.

cholestasis; cholangiopathies; hyperplasia; intrahepatic biliary epithelium; mitosis

This article has been cited by other articles:

				M Marzioni, G Alpini, S Saccomanno, C Candelaresi, J Venter, C Rychlicki, G Fava, H Francis, L Trozzi, and A Benedetti Exendin-4, a glucagon-like peptide 1 receptor agonist, protects cholangiocytes from apoptosis Gut, July 1, 2009; 58(7): 990 - 997. [Abstract] [Full Text] [PDF]

				H. Francis, S. Glaser, S. DeMorrow, E. Gaudio, Y. Ueno, J. Venter, D. Dostal, P. Onori, A. Franchitto, M. Marzioni, et al. Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway Am J Physiol Cell Physiol, August 1, 2008; 295(2): C499 - C513. [Abstract] [Full Text] [PDF]